We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

436 hedge funds and large institutions have $5.76B invested in Teva Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 127 increasing their positions, 135 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

42% more capital invested

Capital invested by funds: $4.07B → $5.76B (+$1.69B)

33% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 58

2% more funds holding

Funds holding: 427 → 436 (+9)

0.32% less ownership

Funds ownership: 54.15% → 53.83% (-0.32%)

6% less repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 135

40% less call options, than puts

Call options by funds: $354M | Put options by funds: $586M

Holders
436
Holders Change
+9
Holders Change %
+2.11%
% of All Funds
8.59%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
77
Increased
127
Reduced
135
Closed
58
Calls
$354M
Puts
$586M
Net Calls
-$232M
Net Calls Change
-$65.6M

Top Buyers

Rank Fund Capital Flow
1
MMH
Menora Mivtachim Holdings
Israel
+$75M
2
MIFH
Migdal Insurance & Financial Holdings
Israel
+$73.7M
3
HIIFS
Harel Insurance Investments & Financial Services
Israel
+$47.7M
4
Two Sigma Investments
Two Sigma Investments
New York
+$21.3M
5
JP Morgan Chase
JP Morgan Chase
New York
+$18.8M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$192M
2
Renaissance Technologies
Renaissance Technologies
New York
-$42M
3
CS
Credit Suisse
Switzerland
-$36.1M
4
Jane Street
Jane Street
New York
-$26.1M
5
CI
Clal Insurance
Israel
-$22.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Schroder Investment Management Group
426
Schroder Investment Management Group
United Kingdom
– -$1.96M -283,811 Closed
LCM
427
Laurion Capital Management
New York
– -$2.4M -269,100 Closed
ARTA
428
A.R.T. Advisors
New York
– -$1.26M -183,892 Closed
Simplex Trading
429
Simplex Trading
Illinois
– -$1.61M -180,136 Closed
LP
430
LMR Partners
United Kingdom
– -$1.03M -150,000 Closed
MFP
431
Michael F. Price
– -$715K -103,910 Closed
CMTU
432
Capital Markets Trading (UK)
United Kingdom
– -$853K -95,563 Closed
BFM
433
Boothbay Fund Management
New York
– -$430K -62,430 Closed
GC
434
Guggenheim Capital
Illinois
– -$332K -48,205 Closed
WCM
435
Weld Capital Management
New York
– -$316K -45,988 Closed
SCM
436
Saba Capital Management
New York
– -$276K -40,187 Closed
SEC
437
Seven Eight Capital
New York
– -$247K -35,845 Closed
OWD
438
Osborn Williams & Donohoe
Ohio
– -$233K -33,868 Closed
ACM
439
Adalta Capital Management
New York
– -$226K -32,800 Closed
M&T Bank
440
M&T Bank
New York
– -$208K -30,303 Closed
CWP
441
Capital Wealth Planning
Florida
– -$234K -28,687 Closed
LOAMU
442
Lombard Odier Asset Management (USA)
New York
– -$254K -28,443 Closed
Point72 Asset Management
443
Point72 Asset Management
Connecticut
– -$189K -27,409 Closed
CCM
444
Cutler Capital Management
Massachusetts
– -$172K -25,000 Closed
QT
445
Quantbot Technologies
New York
– -$152K -22,108 Closed
PP
446
Paloma Partners
Connecticut
– -$135K -19,623 Closed
B
447
Bellecapital
Switzerland
– -$110K -16,000 Closed
Aviva
448
Aviva
United Kingdom
– -$109K -15,885 Closed
Baird Financial Group
449
Baird Financial Group
Wisconsin
– -$109K -15,773 Closed
AFP
450
Ausdal Financial Partners
Iowa
– -$108K -15,653 Closed
16 17
18
19 20

TEVA Hedge Fund Activity: Q4 2019 in Review

436 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q4 2019, worth a combined $5.76B — up 42% from $4.07B a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new TEVA positions and 58 closed out — a net gain of 19 holders — while 127 added to existing stakes and 135 trimmed.

The largest buyer was Menora Mivtachim Holdings, opening a new position worth an estimated $75M. The largest seller was Franklin Resources, cutting an estimated $192M.

  • 436 institutional investors held Teva Pharmaceuticals (TEVA) as of Q4 2019, up from 427 in Q3 2019.
  • Funds reported $5.76B of Teva Pharmaceuticals stock for Q4 2019, up 42% quarter-over-quarter.
  • 77 funds opened new Teva Pharmaceuticals positions in Q4 2019 and 58 closed out, a net change of +19 holders.
  • The largest Teva Pharmaceuticals buyer in Q4 2019 was Menora Mivtachim Holdings, an estimated $75M added.
  • The largest Teva Pharmaceuticals seller in Q4 2019 was Franklin Resources, an estimated $192M sold.

Based on aggregated 13F filings for Q4 2019.